SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-024068
Filing Date
2024-03-19
Accepted
2024-03-19 16:54:05
Documents
14
Period of Report
2024-03-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0202147-8k_golden.htm   iXBRL 8-K 40916
  Complete submission text file 0001213900-24-024068.txt   270156

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE gamc-20240318.xsd EX-101.SCH 4209
3 XBRL DEFINITION FILE gamc-20240318_def.xml EX-101.DEF 27337
4 XBRL LABEL FILE gamc-20240318_lab.xml EX-101.LAB 37938
5 XBRL PRESENTATION FILE gamc-20240318_pre.xml EX-101.PRE 25957
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0202147-8k_golden_htm.xml XML 7454
Mailing Address 10 E. 53RD STREET 13TH FLOOR NEW YORK NY 10022
Business Address 10 E. 53RD STREET 13TH FLOOR NEW YORK NY 10022 212-430-2214
Golden Arrow Merger Corp. (Filer) CIK: 0001841125 (see all company filings)

IRS No.: 861256660 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40223 | Film No.: 24764657
SIC: 2860 Industrial Organic Chemicals
(CF Office: 03 Life Sciences)